Studies of Lassa Virus Cell Entry

Antonella Pasquato1, Antonio Herrador Fernandez1, Stefan Kunz2

  • 1Institute of Microbiology, University Hospital Center, University of Lausanne, Rue du Bugnon 48, CH-1011, Lausanne, Switzerland.

Insights

Lassa virus (LASV) uses multiple cell receptors for entry, including LAMP1, via a unique endocytosis pathway. Researchers investigated this process to find new antiviral therapies targeting viral entry.

Area of Science:

  • Virology
  • Cell Biology
  • Infectious Diseases

Background:

  • Viral entry is crucial for infection and a target for therapeutics.
  • Lassa virus (LASV) utilizes cell receptors like dystroglycan, TAM receptors, and C-type lectins for host cell entry.
  • LASV entry involves a clathrin- and dynamin-independent pathway to late endosomes, requiring LAMP1 for fusion.

Purpose of the Study:

  • To investigate the mechanisms of Lassa virus cell entry.
  • To identify and test potential inhibitors of LASV entry.

Main Methods:

  • Experimental approaches to study LASV cell entry.
  • Testing candidate inhibitors for antiviral activity against LASV entry.

Main Results:

  • Detailed characterization of LASV's receptor usage and entry pathway.
  • Identification of key steps in LASV cell entry.

Conclusions:

  • Understanding LASV entry is vital for controlling zoonotic transmission and viral emergence.
  • Targeting LASV entry presents a promising therapeutic strategy.

Related Concept Videos